Amersham Biosciences, BioDiscovery Fine-tune CodeLink Software

Jan 16, 2003

NEW YORK, Jan. 16-Amersham Biosciences and BioDiscovery will jointly develop and commercialize software to analyze data generated by Amersham CodeLink microarrays, the two companies said today.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Already have an account?
Login Now.

Breaking News

Luminex Receives CE Mark for Aries Acute Gastroenteritis Assay
FDA Approves Abbott's Molecular CMV Assay
Sema4, GNS Healthcare Collaborate on Machine Learning for Therapy Discovery
DuPont Pioneer Licenses CRISPR Tech From ERS Genomics
UCSF Cancer Center Using GenomOncology NGS Analysis Platform
Rennova Health, Certainty Health Partner on Mobile PGx Platform

The Scan

Bit of Uncertainty

The partially reinstated US travel ban leaves space for uncertainty for researchers, Nature News says.

Effect of Sex

Researchers find a number of traits differ by sex and could affect mouse model studies, according to Reuters.

Better Microbes

Tweaking the skin microbiome could help address some skin conditions, the New York Times reports.

This Week in PNAS

In PNAS this week: DNA methylation profiles of tumor tissue, gene dynamics in prokaryotes, and more.

Main menu